SCHEMBL9968581

SCHEMBL9968581

CC(=O)c1cc(S(=O)(=O)NCc2ccc(O)c(O)c2)ccc1OC(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
MAPK1 P28482 3/20 0.43
CYP19A1 P11511 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
POLB P06746 3/20 0.41
ALDH1A1 P00352 3/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HPGD P15428 1/20 0.41
RORC P51449 1/20 0.40
TUBB P07437 1/20 0.40
NAMPT P43490 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968569 0.90 MAPK1 (0.44) KDM4EMAPK1LMNARAB9APOLB
SCHEMBL9968024 0.85 SLC6A2 (0.45) CYP19A1RAB9APOLBSLC6A2SLC6A4
SCHEMBL9968585 0.84 PKM (0.50) CYP19A1ALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL9968023 0.83 SLC6A2 (0.41) MAPK1CYP19A1RAB9APOLBALDH1A1
SCHEMBL15609395 0.83 MAPT (0.60) LMNAPOLBALDH1A1HPGDKMT2A
SCHEMBL9968571 0.81 SLC22A12 (0.43) CYP19A1SLC6A2SLC6A4SLC6A3RORC
SCHEMBL9968476 0.77 ALDH1A1 (0.47) KDM4EMAPK1CYP19A1LMNAPOLB
SCHEMBL15610064 0.75 TSHR (0.60) LMNAPOLBALDH1A1HPGDKMT2A
SCHEMBL9941253 0.73 KMT2A (0.59) LMNAPOLBALDH1A1HPGDKMT2A
SCHEMBL15609194 0.73 MAPT (0.57) LMNAPOLBALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012082862-A2 ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2012-06-21 WO disclosed